Steven Collis, AmerisourceBergen CEO (Alex Brandon/AP Images)

Amerisource­Ber­gen throws down near­ly $1.3B cash for Ger­man life sci­ences com­pa­ny

Amerisource­Ber­gen earned a whop­ping $60.1 bil­lion last quar­ter, thanks in part to its dis­tri­b­u­tion of gov­ern­ment-owned Covid treat­ments. Now it’s time to rein­vest some of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA